SCHEMBL27007641

SCHEMBL27007641

NN(C(=O)c1ccc(Br)cc1F)C(=O)c1ccc(Br)cc1F

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.65
ALDH1A1 P00352 3/20 0.46
NPC1 O15118 2/20 0.46
LMNA P02545 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
KDM4E B2RXH2 1/20 0.39
GLA P06280 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
CES2 O00748 2/20 0.38
CES1 P23141 1/20 0.38
GPR27 Q9NS67 1/20 0.38
PARP15 Q460N3 1/20 0.38
PARP10 Q53GL7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27007759 0.92 DGAT1 (0.56) DGAT1ALDH1A1NPC1LMNARAB9A
Water SCHEMBL27007824 0.91 DGAT1 (0.54) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL27007942 0.89 DGAT1 (0.53) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL21049739 0.89 DGAT1 (0.60) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL27007825 0.87 DGAT1 (0.50) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL18149810 0.86 DGAT1 (0.61) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL646187 0.81 DGAT1 (0.59) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL150293 0.79 DGAT1 (1.00) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL4464312 0.78 DGAT1 (0.70) DGAT1ALDH1A1NPC1LMNARAB9A
SCHEMBL3341268 0.77 DGAT1 (0.54) DGAT1ALDH1A1NPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018121-A1 NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE FOX CHASE CHEMCIAL DIVERSITY CENTER, INC. (US) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018121-A1 NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE ERG28, CYP51A1, MANBA DGAT1 1180/4885ALDH1A1 1109/4885NPC1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.